188 reports of this reaction
2.0% of all EDOXABAN TOSYLATE reports
#10 most reported adverse reaction
FALL is the #10 most commonly reported adverse reaction for EDOXABAN TOSYLATE, manufactured by Daiichi Sankyo Inc.. There are 188 FDA adverse event reports linking EDOXABAN TOSYLATE to FALL. This represents approximately 2.0% of all 9,635 adverse event reports for this drug.
Patients taking EDOXABAN TOSYLATE who experience fall should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FALL is a less commonly reported adverse event for EDOXABAN TOSYLATE, but still significant enough to appear in the safety profile.
In addition to fall, the following adverse reactions have been reported for EDOXABAN TOSYLATE:
The following drugs have also been linked to fall in FDA adverse event reports:
FALL has been reported as an adverse event in 188 FDA reports for EDOXABAN TOSYLATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FALL accounts for approximately 2.0% of all adverse event reports for EDOXABAN TOSYLATE, making it a notable side effect.
If you experience fall while taking EDOXABAN TOSYLATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.